Clinical trials recruiting in Reutlingen, Germany
3
Recruiting trials
15
Conditions
Phase breakdown
Phase 3 1Not applicable 2
Conditions recruiting in Reutlingen, Germany
| Condition | Trials |
|---|---|
| Barth Syndrome | 1 |
| Breast Neoplasms | 1 |
| Breast cancer | 1 |
| CPEO | 1 |
| Coenzyme Q10 Deficiency | 1 |
| Colorectal Cancer | 1 |
| Epilepsy | 1 |
| Kearns-Sayre Syndrome | 1 |
| LHON | 1 |
| Leigh Syndrome | 1 |
| MDS | 1 |
| MELAS Syndrome | 1 |
| MERRF Syndrome | 1 |
| MIDD | 1 |
| MIRAS | 1 |
Recruiting trials in Reutlingen, Germany
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
- Global Registry and Natural History Study for Mitochondrial Disorders
- Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
Common questions
How many clinical trials are recruiting in Reutlingen, Germany?
3 recruiting trials have at least one study site in Reutlingen, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.